Matas A/S (LON:0QFA)
122.40
+0.40 (0.33%)
At close: Dec 12, 2025
Matas Revenue
Matas had revenue of 1.95B DKK in the quarter ending September 30, 2025, with 5.08% growth. This brings the company's revenue in the last twelve months to 8.59B, up 6.42% year-over-year. In the fiscal year ending March 31, 2025, Matas had annual revenue of 8.38B with 25.04% growth.
Revenue (ttm)
8.59B DKK
Revenue Growth
+6.42%
P/S Ratio
0.54
Revenue / Employee
1.63M DKK
Employees
5,260
Market Cap
539.91M GBP
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 8.38B | 1.68B | 25.04% |
| Mar 31, 2024 | 6.70B | 2.21B | 49.28% |
| Mar 31, 2023 | 4.49B | 144.80M | 3.33% |
| Mar 31, 2022 | 4.34B | 180.60M | 4.34% |
| Mar 31, 2021 | 4.16B | 475.10M | 12.88% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |